Startup Funding Tracker
Home›People›Amy Kruse
AK

Amy Kruse

Director at Cognixion

DirectorRoles at 5 startups
LinkedIn
Updated Nov 9, 2026·Latest SEC filing Oct 21, 2026·Suggest an edit

About Amy Kruse

Amy Kruse is a director of Cognixion, which makes brain interfaces for people with complex disabilities.

She has held general partner and venture partner roles at Prime Movers Lab. She was also set to join Morphoceuticals' board.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Amy Kruse in the role, so the role may have started earlier or lasted longer.

Cognixion Corp Current
Prime Movers Lab and director
2021 – Present · Santa Barbara, DE
Cognixion builds wearable brain interfaces that help people with complex disabilities communicate and control connected technology.
Prime Movers Lab Current
General Partner
Venture Partner
Gilgamesh Pharma Inc.
Director
2026 · New York, NY
Develops medicines for people with psychiatric and neurological disorders.
Motif Neurotech, Inc.
Director
2024 · Houston, TX
Paradromics, Inc.
Director
2021 – 2023 · Austin, TX
Morphoceuticals, Inc.
Director
2023 · Medford, MA

Key Colleagues at Startups

The people Amy Kruse works with at each company, as listed on that company's latest Form D.

Cognixion Corp · Form D, Oct 21, 2026
Andreas Forsland
Andreas Forsland
Founder and CEO, director
TG
TW
JK
Gilgamesh Pharma Inc. · Form D, Mar 31, 2026
Jonathan Sporn
Jonathan Sporn
Founder, CEO and director
PS
ZH
Zia Huque
Director
RB
Andrew Kruegel
Andrew Kruegel
Co-Founder, CSO and director
Motif Neurotech, Inc. · Form D, Jan 24, 2024
Anthony Arnold
JR
Jacob Robinson
Chief Executive Officer and director
TS
Paradromics, Inc. · Form D/A, Nov 7, 2023
HE
Helmy Eltoukhy
Executive officer and director
MA
Matthew Angle
CEO and director
ZH
Zia Huque
Director
Morphoceuticals, Inc. · Form D, Jan 23, 2023
AP
ML
DG
David Gill
Executive officer
DK
David Kaplan
Promoter
MH
Michael Hufford
Interim Chief Executive Officer and director
RH

Amy Kruse in the News

Sources

  1. SECCognixion Corp Form D, filed Oct 21, 2026
  2. SECGilgamesh Pharma Inc. Form D, filed Mar 31, 2026
  3. SECMotif Neurotech, Inc. Form D, filed Jan 24, 2024
  4. SECParadromics, Inc. Form D/A, filed Nov 7, 2023
  5. SECMorphoceuticals, Inc. Form D, filed Jan 23, 2023
  6. P1Cognixion funding announcement
  7. P2Cognixion website
  8. P3Morphoceuticals announcement